300
Participants
Start Date
February 28, 2013
Primary Completion Date
April 30, 2015
Study Completion Date
April 30, 2015
daily fluticasone propionate
Flovent® HFA, 44 mcg per inhalation, 2 inhalations twice daily
Montelukast
Singulair®, 4 mg granules or chewable tablets by mouth once daily in the evening
as-needed fluticasone propionate
Flovent® HFA, 44 mcg per inhalation, 2 inhalations, as needed for asthma symptoms
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
University of Virginia Health System, Charlottesville
Emory University, Atlanta
Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland
University of Wisconsin-Madison, Madison
Rush University Medical Center/Stroger Hospital, Chicago
Children's Memorial Hospital, Chicago
St. Louis Children's Hospital, St Louis
National Jewish Health, Denver
University of Arizona College of Medicine, Tucson
UCSF Benioff Children's Hospital, San Francisco
Children's Hospital & Research Center Oakland, Oakland
Children's Hospital, Boston, Boston
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Milton S. Hershey Medical Center
OTHER